Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants.
Saved in:
| Title: | Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants. |
|---|---|
| Authors: | Churchyard G; Aurum Institute for Health Research, Klerksdorp, South Africa.; School of Public Health, University of Witwatersrand, Johannesburg, South Africa.; Advancing Care and Treatment for TB and HIV, Medical Research Council Collaborating Centre, Klerksdorp, South Africa., Mlisana K; University of Kwa-Zulu Natal, Durban, South Africa., Karuna S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America., Williamson AL; Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, University of Cape Town, Cape Town, South Africa; National Health Laboratory Services, Observatory, Cape Town, South Africa., Williamson C; Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, University of Cape Town, Cape Town, South Africa; National Health Laboratory Services, Observatory, Cape Town, South Africa., Morris L; National Institute for Communicable Diseases, National Health Laboratory Services, Sandringham, Johannesburg, South Africa., Tomaras GD; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, United States of America., De Rosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.; Department of Laboratory Medicine, University of Washington, Seattle, WA, United States of America., Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America., Gu N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America., Yu C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America., Mkhize NN; National Institute for Communicable Diseases, National Health Laboratory Services, Sandringham, Johannesburg, South Africa., Hermanus T; National Institute for Communicable Diseases, National Health Laboratory Services, Sandringham, Johannesburg, South Africa., Allen M; Vaccine Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America., Pensiero M; Vaccine Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America., Barnett SW; Novartis Vaccines and Diagnostics, Cambridge, MA, United States of America., Gray G; South African Medical Research Council, Cape Town, South Africa.; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Braamfontein, Johannesburg, South Africa., Bekker LG; Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Montefiori DC; Laboratory for AIDS Vaccine Research and Development, Duke University Medical Center, Durham, NC, United States of America., Kublin J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.; Department of Laboratory Medicine, University of Washington, Seattle, WA, United States of America. |
| Source: | PloS one [PLoS One] 2016 Sep 01; Vol. 11 (9), pp. e0161753. Date of Electronic Publication: 2016 Sep 01 (Print Publication: 2016). |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
